Why IMI PARADIGM? – The industry perspective

At EFPIA, we work across a wide spectrum of topics from prevention and awareness, through research and development (R&D), regulatory and Health Technology Assessment (HTA) processes, managing relationships, to developing healthcare service design and outcomes measurement. Each one has a direct impact on the lives of patients, their families and carers across Europe.
Actively listening to patient experiences and patient challenges, and exchanging insights, must shape how we develop our policy, processes and practice. It is only through open and transparent dialogue between patients, industry and other key stakeholders that we can ensure the patient perspective becomes an integral part of how medicines are researched, developed and delivered to patients. 

You can read the full blog on the PARADIGM website 

Nathalie Moll

Nathalie Moll joined the European Federation of Pharmaceutical Industries and Associations (EFPIA) as Director...
Read Morechevron_right